Gore Ventures
The Federal Commission for Protection against Sanitary Risks (COFEPRIS) has recently authorized a pioneering clinical trial, which aims to assess the effectiveness of the GORE synthetic cornea device in patients suffering from corneal clarity loss.
Leading Direct Air Capture Company CarbonCapture Inc. (CarbonCapture) and W. L. Gore & Associates (Gore) today announced a multi-year collaboration to develop advanced structured sorbents for more efficient atmospheric carbon removal.
An investigational integrated glaucoma drainage implant prototype can create thinner, more permeable blebs.
Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not “sell” the personal information of website users. Gore may “share” the personal information of website users, as standard advertising practice meant to offer you a more personalized service.
If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.
Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.
You Have Successfully Opted Out of the Sharing of Your Personal Information
Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.